Enthea
United States
- Boston
- 19/12/2022
- Seed
- $2,000,000
Psychedelic Healthcare as a Workplace Benefit.
Creating benefit plans for progressive, compassionate employers.
We are on a mission to expedite safe, affordable access to psychedelic-assisted therapy for all who can benefit.
Supporting healing from within.
- Industry Insurance and Employee Benefit Funds
- Website https://www.enthea.com/
- LinkedIn https://www.linkedin.com/company/entheahealth/
Related People
Sherry R.Founder
Canada -
Toronto, Ontario
I have helped dozens of startups, non-profit organizations, academic/research institutions, and small businesses raise funds, operate according to their mission and values, and implement processes that enhance their efficiency.
I believe in living and working in alignment with purpose and I am currently focused on expanding access to psychedelic-assisted therapy to alleviate human suffering.
Before this, I consulted with the United Nations and World Bank for 10 years, implementing cash transfer programs at the national level in over 35 countries.
I have a Master’s Degree in Public Policy and Management from the London School of Economics and a Bachelor’s Degree in Neuroscience and International Development from McGill University. I also completed the Certificate in Psychedelic Therapies and Research from CIIS in 2021.
In addition to being Enthea's CEO, I am the Executive Director of the Boston Psychedelic Research Group, HR Consultant for Sensorium Therapeutics, and Strategic Advisor for CIIS.
Inception | $50,000,000 | (Nov 7, 2025)
SiteLabs | $2,000,000 | (Nov 7, 2025)
DealMaker | $20,000,000 | (Nov 7, 2025)
Flint(US) | $15,000,000 | (Nov 7, 2025)
Subtle Computing | $6,000,000 | (Nov 7, 2025)
IndustrialMind.ai | $1,200,000 | (Nov 7, 2025)
Fintary | $10,000,000 | (Nov 7, 2025)
Graymatter Labs | $1,300,000 | (Nov 7, 2025)
Avallon AI (YC X25) | $4,600,000 | (Nov 7, 2025)
Kaizen Labs | $12,000,000 | (Nov 7, 2025)
Giga | $61,000,000 | (Nov 7, 2025)
Reevo | $80,000,000 | (Nov 7, 2025)